Matches in SemOpenAlex for { <https://semopenalex.org/work/W4386021397> ?p ?o ?g. }
- W4386021397 abstract "ABSTRACT Background The global Viral hepatitis elimination by 2030 is uncertain in resource-limited settings (RLS), due to high burdens and poor diagnostic coverage. This sounds more challenging for hepatitis C virus (HCV) given that antibody (HCVAb) sero-positivity still lacks wide access to HCV RNA molecular testing. This warrants context-specific strategies for appropriate management of liver impairment in RLS. We herein determine the association between anti-HCV positivity and liver impairment in an African RLS. Methods A facility-based observational study was conducted from July-August 2021 among individuals attending the “St Monique” Health Center at Ottou, a rural community of Yaounde,Cameroon. Following a consecutive sampling, consenting individuals were tested for anti-HCV antibodies, hepatitis B surface antigen (HBsAg) and HIV antibodies (HIVAb) as per the national guidelines. After excluding positive cases for HBsAg and/or HIVAb, liver function tests (ALT/AST) were performed on eligible participants (HBsAg and HIVAb negative) and outcomes were compared according to HCVAb status; with p<0.05 considered statistically significant. Results Out of 306 eligible participants (negative for HBsAg and HIVAb) enrolled, the mean age was 34.35±3.67 years. 252(82.35%) were female and 129 (42.17%) were single. The overall HCVAb sero-positivity was 15.68%(48/306), with 17.86% (45/252) among women vs. 5.55%(3/54) among men [OR (95%CI)=3.69(2.11-9.29), p =0.04]. HCVAb Carriage was greater among participants aged >50 years compared to younger ones [38.46%(15/39) versus 12.36% (33/267) respectively, OR(95%CI)=4.43(2.11-9.29), p<0.000] and in multipartnership [26.67%(12/45)vs.13.79%(36/261) monopartnership, OR (95%CI)= 2.27(1.07-4.80), p =0.03]. The liver impairment rate (abnormal ALT+AST levels) was 30.39%(93/306), with 40.19%(123/306) of abnormal ALT alone. Moreover, the burden of Liver impairment was significantly with aged>50 versus younger ones [69.23% (27/39) versus 24.72%(66/267) respectively, p<0.000). Interestingly, the burden of liver impairment (abnormal AST+ALAT) was significantly higher in HCVAb positive (62.5%, 30/48) versus HCVAb negative (24.42%, 63/258) participants, OR: 3.90 [1.96; 7.79], p=0.0001. Conclusions In this rural health facility, HCVAb is highly endemic and the burden of liver impairment is concerning. Interestingly, HCVAb carriage is associated with abnormal liver levels of enzyme (ALT/AST), especially among the elderly populations. Hence, in the absence of nuclei acid testing, ALT/AST are relevant sentinel markers to screen HCVAb carriers who require monitoring/care for HCV-associated hepatocellular carcinoma in RLS." @default.
- W4386021397 created "2023-08-22" @default.
- W4386021397 creator A5004982350 @default.
- W4386021397 creator A5034954021 @default.
- W4386021397 creator A5042539877 @default.
- W4386021397 creator A5049803092 @default.
- W4386021397 creator A5062291059 @default.
- W4386021397 creator A5078478462 @default.
- W4386021397 creator A5079866720 @default.
- W4386021397 creator A5092806704 @default.
- W4386021397 creator A5092806705 @default.
- W4386021397 date "2023-08-21" @default.
- W4386021397 modified "2023-10-09" @default.
- W4386021397 title "Anti-Hepatitis C Antibody Carriage and Risk of Liver Impairment in Rural-Cameroon: Adapting the Control of Hepatocellular Carcinoma for Resource-Limited Settings" @default.
- W4386021397 cites W1876982146 @default.
- W4386021397 cites W1973319529 @default.
- W4386021397 cites W1978091752 @default.
- W4386021397 cites W1996248227 @default.
- W4386021397 cites W2000307707 @default.
- W4386021397 cites W2039537887 @default.
- W4386021397 cites W2049923191 @default.
- W4386021397 cites W2090693574 @default.
- W4386021397 cites W2090915231 @default.
- W4386021397 cites W2091185925 @default.
- W4386021397 cites W2093494646 @default.
- W4386021397 cites W2106791445 @default.
- W4386021397 cites W2109035408 @default.
- W4386021397 cites W2116460737 @default.
- W4386021397 cites W2147193438 @default.
- W4386021397 cites W2153565848 @default.
- W4386021397 cites W2163868588 @default.
- W4386021397 cites W2170757389 @default.
- W4386021397 cites W2177258682 @default.
- W4386021397 cites W2345850872 @default.
- W4386021397 cites W2565810568 @default.
- W4386021397 cites W2569037451 @default.
- W4386021397 cites W2767286688 @default.
- W4386021397 cites W2784116013 @default.
- W4386021397 cites W2791741379 @default.
- W4386021397 cites W2792087431 @default.
- W4386021397 cites W2801528811 @default.
- W4386021397 cites W2861489047 @default.
- W4386021397 cites W2911349635 @default.
- W4386021397 cites W2922720368 @default.
- W4386021397 cites W2945872312 @default.
- W4386021397 cites W2974088896 @default.
- W4386021397 cites W2979353639 @default.
- W4386021397 cites W2991934814 @default.
- W4386021397 cites W3006783583 @default.
- W4386021397 cites W3024122151 @default.
- W4386021397 cites W3037466317 @default.
- W4386021397 cites W3045688043 @default.
- W4386021397 cites W3129065841 @default.
- W4386021397 cites W3178522881 @default.
- W4386021397 cites W4211207065 @default.
- W4386021397 cites W4245656833 @default.
- W4386021397 cites W4312443927 @default.
- W4386021397 cites W4313253279 @default.
- W4386021397 cites W4320482487 @default.
- W4386021397 cites W4323843527 @default.
- W4386021397 doi "https://doi.org/10.1101/2023.08.16.23294167" @default.
- W4386021397 hasPublicationYear "2023" @default.
- W4386021397 type Work @default.
- W4386021397 citedByCount "0" @default.
- W4386021397 crossrefType "posted-content" @default.
- W4386021397 hasAuthorship W4386021397A5004982350 @default.
- W4386021397 hasAuthorship W4386021397A5034954021 @default.
- W4386021397 hasAuthorship W4386021397A5042539877 @default.
- W4386021397 hasAuthorship W4386021397A5049803092 @default.
- W4386021397 hasAuthorship W4386021397A5062291059 @default.
- W4386021397 hasAuthorship W4386021397A5078478462 @default.
- W4386021397 hasAuthorship W4386021397A5079866720 @default.
- W4386021397 hasAuthorship W4386021397A5092806704 @default.
- W4386021397 hasAuthorship W4386021397A5092806705 @default.
- W4386021397 hasBestOaLocation W43860213971 @default.
- W4386021397 hasConcept C126322002 @default.
- W4386021397 hasConcept C142724271 @default.
- W4386021397 hasConcept C151730666 @default.
- W4386021397 hasConcept C203014093 @default.
- W4386021397 hasConcept C23131810 @default.
- W4386021397 hasConcept C2522874641 @default.
- W4386021397 hasConcept C2776408679 @default.
- W4386021397 hasConcept C2776455275 @default.
- W4386021397 hasConcept C2777382497 @default.
- W4386021397 hasConcept C2777410769 @default.
- W4386021397 hasConcept C2778019345 @default.
- W4386021397 hasConcept C2779343474 @default.
- W4386021397 hasConcept C2780593183 @default.
- W4386021397 hasConcept C32762888 @default.
- W4386021397 hasConcept C71924100 @default.
- W4386021397 hasConcept C86803240 @default.
- W4386021397 hasConcept C90924648 @default.
- W4386021397 hasConceptScore W4386021397C126322002 @default.
- W4386021397 hasConceptScore W4386021397C142724271 @default.
- W4386021397 hasConceptScore W4386021397C151730666 @default.
- W4386021397 hasConceptScore W4386021397C203014093 @default.
- W4386021397 hasConceptScore W4386021397C23131810 @default.
- W4386021397 hasConceptScore W4386021397C2522874641 @default.
- W4386021397 hasConceptScore W4386021397C2776408679 @default.
- W4386021397 hasConceptScore W4386021397C2776455275 @default.